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Abstract:
Two dimensional correlation analysis is explored to data mine the time evolution of the
characteristic Raman microspectroscopic signatures of the subcellular responses of the
nucleoli of human lung cancer cells to the uptake of doxorubicin. A simulated dataset of
experimental control spectra, perturbed with systematically time-dependent spectral changes,
constituted by a short term response which represents the initial binding of the drug in the
nucleolus, followed by a longer term response of the organelle metabolism, is used to validate
the analysis protocol. Applying two dimensional correlation analysis, the in phase,
synchronous correlation co-efficients are seen to contain contributions of both response
profiles, whereas they can be independently extracted from the out of phase, asynchronous
correlation co-efficients. The methodology is applied to experimental data of the uptake of
doxorubicin in human lung cell lines to differentiate the signatures of chemical binding and
subsequent cellular response.

1. Introduction
In the field of label free analysis and imaging, vibrational spectroscopic microscopy has
emerged as an alternative for high content analysis of cells in vitro, which can provide
molecularly specific signatures of biological processes and function.[1–3] Quantitative
spectroscopic changes attributable to the biochemical processes occurring during cell culture
and mitosis,[4,5] proliferation,[6] differentiation and activation,[7–9] adhesion,[10] death[11] and
invasion[12] have previously been documented. In particular, Raman microspectroscopy can
be performed at visible wavelengths in a confocal mode and can provide details at a
subcellular level, of fixed or live cells,[2,3,13] enabling, for example, the detection of cellular
mitochondrial distribution[14] and phagosomes.[15]
Both infrared absorption (IR) and Raman microspectroscopy have been used to assess the
effects of drugs on cells, demonstrating the potential to measure changes in a label free, high
throughput manner and therefore be used in pre-clinical drug screening.[16–19] Raman
microspectroscopic analyses of drug-cell interactions have focused both on changes in the
cellular Raman spectra upon drug application, during intracellular tracking of the drug and its
metabolites, as well as cellular resistance[20–22]
The emerging nonlinear Raman microspectroscopic techniques of coherent anti-Stokes and
stimulated Raman scattering[23], and indeed technological advances in infrared spectroscopic
analysis[24,25], promise label free high content spectroscopic analysis of sub-cellular processes
in real-time, and hitherto unrivalled visualisation of cellular processes and function. It is
becoming increasingly important, therefore, to explore protocols for harnessing and
interpreting the high content spectral information which such label free techniques can yield.
Critically, the analysis and interpretation of the spectral responses remains a challenge, even
in the hands of “specialists”. By their very nature, label free techniques register all species
within the sampling area, and identification of specific responses requires multivariate

analytical techniques to data-mine the differential signatures which are characteristic of cell
injury events or response pathways.
Previous studies have demonstrated the ability of Partial Least Squares Regression (PLSR)
and Independent Components Analysis (ICA), and/or a combination thereof, to monitor the
uptake of chemotherapeutic agents, and to differentiate between the spectral signatures of the
initial chemical binding of Cisplatin,[26,27] Vincristine[28] and more recently Doxorubicin
(DOX)[29–32] and Actinomycin D[33] in A549 and Calu-1 human lung cancer cells from the
subsequent cellular response pathway. Notably, however, in the case of the DOX study, the
analysis was based on the identification of two independent regimes of the temporal spectral
evolution, clearly identifiable by the build-up, and saturation of the DOX Raman signature,
initially in the nucleolus (~2-6 hrs), and subsequently nucleus of the cell (~6-12 hrs), before it
was detectable in the cytoplasmic region (~24-48 hrs). The initial stages of the build up of the
drug in the subcellular region were analysed independently from the regions of saturation,
and the spectral signatures were interpreted in terms of the initial binding interactions of the
drug in the organelle, and the subsequent metabolic response of the organelle. For automated
analysis of more general cell exposure scenarios, in which for example the exogenous agent
is not clearly identifiable in the cell by its strong Raman signature, an integrated objective
multivariate data-mining algorithm is desirable.
Two dimensional correlation analysis is an alternative data analysis protocol, which was
developed by Noda[34] as a method of quantifying the relationship between spectral features
that vary systematically as a function of an evolving parameter or physical quantity, such as
time. Quaroni et al.[35] have demonstrated its use to assign the biochemical origin of weak
absorption changes in time-resolved FT-IR spectromicroscopy of individual cells, and to
perform real-time metabolic analysis of living cancer cells.[36]

The application of two dimensional correlation analysis to a data set involves calculation of
the correlation function of the evolving spectral profiles followed by application to the latter
of a 2-D Fourier transform algorithm. The result is a complex function of two wavenumber
variables that is plotted as separate real and imaginary components. The plot of the real
component is called the synchronous plot, and that of the imaginary component the
asynchronous plot. The former represents correlations between pairs of wavenumbers that
evolve fully in phase, or with opposite phase. The latter represents correlations between pairs
of wavenumbers that have an out-of-phase relationship. The principle of the technique is that
the in phase spectral features should evolve synchronously with the time evolution, whereas
the out of phase, asynchronous spectral features evolve over a later timescale.[37,38]
In this study, the potential of two dimensional correlation analysis to simultaneously identify,
in a single analytical protocol, the characteristic of Raman microspectroscopic signatures of
both the early stage binding of chemotherapeutic agents in the nucleolus of cells, as well as
the subsequent cellular responses will be demonstrated. Raman microspectroscopic data from
the previous studies of DOX uptake by and response of the nucleolar regions of A549 and
Calu I (Supplemental Material), human lung cancer cells will be employed, and the results
will be compared to those of the previous PLSR/ICA analysis.[39] In order to validate the
technique, simulated spectral datasets, based on systematic perturbations of the control
datasets of the previous experimental studies, will be employed.

2. Materials and Methods
The details of experimental methods and protocols are described in greater detail in the original
publications[31,39–41], but are summarised here. The experimental workflow of cell culture and drug
exposure, for varying times, cytotoxicity assessment, fixation, subcellular Raman microscopic
analysis, data preprocessing and analysis is depicted in Figure 1.
2.1. Materials

A549 human lung adenocarcinoma cells with the alveolar type II phenotype were obtained from
ATTC (Manassas, VA, USA) and Calu-1 human lung epidermoid carcinoma cells were obtained
from the European Collection of Cell Cultures.
Doxorubicin hydrochloride® powder (Sigma Life Sciences, Ireland) was diluted in 1 mL sterile
water, to the required concentration of 0.6 μM, identified by cytotoxicological analysis[33,41].
2.2. Cell Culture
A549 cells were cultured in DMEM (with 2 mM L-glutamine) with 10 % foetal bovine serum (FBS)
and Calu-1 cells in RPMI with 10% FBS, both at 37 °C in a humidified atmosphere containing 5%
CO2 and cells were split every two days to maintain ~60 % confluence.
2.3. Raman Spectroscopy
Cells (~ 3 x 103/cm2) were seeded and incubated on (20 mm diameter) CaF2 windows (Crystan Ltd,
UK) for 24 hrs for both control and exposure to chemotherapeutic drug. Medium was then removed
and samples were rinsed twice with sterile phosphate buffered saline (PBS) and covered with aqueous
solutions of DOX, of concentration 0.6 μM. After each incubation period, cells were washed twice
with sterile PBS and fixed in formalin (10 %, 15 min) and allowed to air dry.
A Horiba Jobin-Yvon LabRAM HR800 spectrometer with a 785 nm, 300 mW diode laser as source
(~100 mW at the sample), Peltier cooled 16-bit CCD, 300 lines/mm grating and 100 μm confocal
hole, was used for this work. Spectra were acquired from the three visually identifiable cell locations:
cytoplasm, nucleus and nucleolus, in the range from 400 cm-1 to 1800 cm-1 with a x100 objective
(LCPlanN, Olympus) for 30 s two times, to finally produce a data set of 30 points per cell location for
each cell line, over a total of 210 different cells. In this study, only spectra of the nucleoli are
considered.
2.4. Data Processing and Analysis
Raman spectral pre-processing and analysis were performed in Matlab using algorithms developed in
house. Prior to analysis, background was subtracted using a NCLS (non-negatively constrained least

squares) algorithm, spectra were smoothed (Savitsky-Golay filter 3th order, 11 points), baseline
corrected (fifth order polynomial) and vector normalised.
Two dimensional correlation analysis was conducted using the MIDAS2010 Graphical User
Interface (GUI) originally developed by researchers in the Canadian Light Source for two
dimensional correlation analysis and data exploration of time resolved infrared spectra.[42]
The GUI is available for download from MathWorks File Exchange,[42] and is recommended
to be run in Matlab 7.6 (R2008a), with the Image Processing Toolbox. The spectral data
should be loaded as a tab delimited text file with extension .txt, containing a matrix with [m
n] dimensions. The first column of the matrix contains the spectral range (wavenumbers),
while the remaining columns contain sample spectra. It is assumed that the dynamic variable
(time), is incremented by a constant amount. Note, it was observed that the GUI does not read
the final spectrum column, and therefore this was duplicated in a column n+1.
3. Two dimensional correlation analysis of simulated spectral responses
3.1. Generation of Simulated Spectral Responses
The analysis of the kinetic uptake of DOX by A549 cells and subsequent cellular response by
Farhane et al.[39] indicated the evolution of an initial response associated with the chemical
interaction of the chemotherapeutic agent with the RNA/DNA in the nucleolus of the cell,
and a subsequent longer term response associated with reaction of the cell metabolism.
According to the observations of this study, a simplified representation of the initial response
signature (Response 1) can be modelled based on a reduction of the prominent peaks
observed at 785 cm-1 (RNA/DNA O–P–O stretching), 810 cm-1 (RNA O–P–O stretching),
1095 cm-1 (DNA PO2− symmetric stretching) and 1683 cm-1 (protein Amide I), as shown in
Figure 2(a). Similarly, the spectral signature of the longer term cellular response (Response
2) can be represented by increases in the prominent peaks at 1047 cm-1 (RNA P–O stretching,

sugar phosphate –C–O–stretching), 1271 cm-1 (protein Amide III) and 1444 cm-1 (lipid CH2
deformation).
The time evolution of these responses can be modelled by a simple rate equation approach,
such that:
The number of bound DOX molecules, Nb, is represented as a function of time by
dNb/dt = (Nrecp – Nb)KupD

(1)

where Nrecp is the number of receptor sites for DOX binding in the cell nucleolus, D is the
DOX dose, and Kup is the rate of uptake of DOX into the nucleolus of the cell. The spectral
response of the cell to DOX binding is assumed to be instantaneous, and therefore the
spectral response is weighted according to:
Response 1 (t) = Response 1 x Nb(t)

(2)

The time evolution of the subsequent cellular response, Nr, can similarly be modelled
according to:
dNr/dt = (Nresp – Nr)KrespNb

(3)

where Nresp acts as a limit to the total response, and Kresp is the response rate. The spectral
response of the cell to DOX binding is assumed to evolve at this rate, and therefore the
spectral response is weighted according to:
Response 2 (t) = Response 2 x Nr(t)

(4)

Figure 2(b) shows the simulated temporal evolution of the spectral responses, using rates of
Kup = 2.5 x 10-4 and Kresp = 5x10-6 hr-1.
To simulate the time evolution of the intrinsic spectral response of the nucleus of A549 cells
to DOX exposure, the simulated spectral responses in Figure 2(a), can be added to the

experimental mean control spectra (Figure 2(a)), weighted at a given exposure time by the
simulated response of Figure 2(b). Response 1 is weighted negatively, to represent the
experimentally observed reduction in the identified features of nucleic acids. In both cases, an
additional weighting of 0.05 was applied, to better mimic the experimental observations.
Figure 2(c) shows a zoom of the spectral region from 700-1200 cm-1, illustrating the control
spectrum and the simulated spectra at (as examples) 20 and 72 hrs DOX exposure.
3.2. 2D Correlation Analysis of Simulated Spectral Responses
The simulated spectral response data set, including simulated responses over the exposure
period of 0-72 hrs, at 2 hour intervals, was analysed using the MIDAS 2010 two dimensional
correlation analysis GUI package.[42] Figure 3a shows the synchronous correlation analysis
in contour form, while Figure 3b shows the same plot, after subtraction of the control
spectrum (0 hrs) from the dataset, as a static component. Both are symmetric with respect to
the diagonal, as expected. Before subtraction, the 2D contour plot shows multiple positive
correlations for all peaks, and the diagonal cross section contains contributions of all spectral
components integrated over the exposure time range (data not shown). Subtraction of the
static component greatly simplifies the correlation plot, as shown in Figure 3b. Again, the
diagonal autocorrelation shows positive peaks for all spectral features of Response 1 and
Response 2, as shown in Figure 4(a). Features of the off diagonal, cross peaks represent
positive correlations for Response 1, and negative correlations for Response 2. A vertical
cross section at x= 785 cm-1, shown in Figure 4(b), demonstrates that the spectral
contributions of both Response 1 and Response 2 are represented, although with opposite
signs to their contributions to the source spectra. The same applies to a horizontal crosssection at y= 785 cm-1. Furthermore, although their contributions are weighted equally in the
simulated spectra, the relative contributions of the spectral responses to the correlation is not
the same, Response 2 being relatively weaker. Notably, with no a priori knowledge of the

origin of the features, it is not obvious that negative and positive correlations have different
temporal evolutions. Although Response 1 and 2 have clearly different temporal profiles,
they both evolve synchronously as a function of time.
Figure 5(a) shows the asynchronous correlation plot, which in this case is independent of
subtraction of control and, as expected, is asymmetric with respect to the diagonal. Reading
vertically at a (x) wavenumber corresponding to a feature of Response 1, the features of
Response 2 are positively, asynchronously correlated, while reading vertically at wavenumbers
of Response 2 features, Response 1 features are negatively, asynchronously correlated, as
shown in Figure 5(b). The behaviour is inverted when reading horizontally from (y)
wavenumbers of Response 1 or Response 2 features. Furthermore, although not identical, the
weightings of the two Response features are approximately equal.
The asynchronous contour plot thus clearly better illustrates that the spectral profile of
Response 1 and Response 2 are decoupled and can be differentiated by two dimensional
correlation analysis. The synchronous autocorrelation can be employed to identify the spectral
features of the changes to the system, while the features of the asynchronous correlation plot
can be employed to differentiate the responses of differing time evolution.
Notably, however, the analysis does little to elucidate the temporal evolution of the responses,
as simulated according to Figure 2. In fact, although the diagonal autocorrelation of Figure 3
reproduces the spectral perturbations of Figure 2, the weightings of Response 1 and 2 are not
equal, as shown in Figure 4(a), as the correlation function integrates over the exposure time of
72 hours. Figure 6(a) shows a plot of the correlation over an expanding time window of 0-T,
as T is increased from 4 hrs to 72 hrs (i.e. 0-2 hrs, 0-4hrs, 0-6hrs etc.). The integrated
contribution of the Response 1 feature at 785 cm-1, for example, is considerably stronger than
that of Response 2 at 1047 cm-1 over the time range. If the correlation is instead performed

over a fixed, moving window, T (e.g. 0-4hrs, 2-6hrs, 4-8hrs etc.), the temporal evolution of
the respective spectral features is better reproduced, as shown in Figure 6(b) for T=4 hrs.
This is done by manually limiting the dataset to the range T1-T2, and extracting the correlation
data for each range, which is rather laborious and is not easily facilitated by the MIDAS 2010
GUI. Rather, the MIDAS 2010 GUI plots features of the original spectral data as a function of
time, whether before or after subtraction of a static background, if appropriately identified by
the correlation procedure (Figure 6(c)).
4. Two dimensional correlation analysis of Experimental Datasets
4.1. A549 Nucleolus after DOX exposure
Figure 7(a) shows the synchronous contour plot of the two dimensional correlation analysis
of experimental data of Raman microspectroscopic analysis of the nucleoli of A549 cells
exposed to DOX at the IC50 concentration of 0.6M (24 hrs, MTT assay) over a period of 072 hrs, as reported by Farhane et al..[39] The zero hour control has been subtracted as a static
component. Figure 7(b) shows the corresponding asynchronous contour plot. The diagonal
autocorrelation profile is dominated by the spectrum of DOX, as shown in Figure 8, which
has strong features at, for example, 440 cm-1, 465 cm-1 (C-C-O and C-O), bands
corresponding to C-O, C-O-H and C-H in the region between 1200 and 1300 cm-1, and at
1445 and 1570 cm-1, related to skeletal ring vibrations[43,44]. In addition, there are a number of
weaker peaks evident in the region of ~780 cm-1, 1000-1100 cm-1, and ~1600 cm-1, which
represent the cellular responses to DOX exposure[39].
By analogy to the analysis of the simulated spectral model of Section 3, the independent
evolutions of the spectral responses are best extracted by analysis of the asynchronous
correlation plot (Figure 7(b)). Of specific interest is the instantaneous response of cellular
spectral features as a result of DOX binding, which are directly correlated with the time
dependent evolution of the DOX spectrum, as represented by the strongest DOX peak at 1217

cm-1 and the subsequent evolution of the cellular spectra as a result of the interaction. Figure
9(a) shows the vertical cross section of the asynchronous correlation analysis at a wavenumber
of 1217 cm-1. The appearance of characteristic DOX features at ~440 cm-1 and 1220 cm-1 may
be the result of metabolisation or aggregation of the drug in the cell nucleolus. Additional
prominent features at ~1047 cm-1, 1200-1300 cm-1, and ~1440 cm-1 may be associated with the
long term cellular response to drug binding in the nucleolus of the cell. The spectral profile of
the vertical cross section at 1047cm-1 reveals negatively correlated features at 785 cm-1 and 810
cm-1, as well as a weaker feature at ~1090 cm-1 and a broader feature at ~1640 cm-1, as shown
in Figure 9(b).
By analogy to the analysis of the simulated data of Figure 3, the peaks of the asynchronous
features identified in figures 9 can be considered to be associated with spectroscopic signatures
of the responses of the nucleolus to uptake of the chemotherapeutic agent, DOX (b), and the
subsequent cellular responses (a), respectively. The initial response is correlated with the DOX
spectroscopic profile and thus may be considered as the signature of the initial chemical
binding of the DOX with nucleolar RNA, while the second spectral signature, asynchronous
with the DOX signature, is characteristic of the subsequent cellular response, in the nucleolus.
Figure 10 plots the temporal evolution of the spectral features, after subtraction of the control
spectrum, of the DOX exposed A549 nucleolus, at 465 cm-1 (DOX), 785 cm-1 (RNA/DNA O–
P–O stretching) and 1047 cm-1 (RNA P–O stretching, sugar phosphate –C–O–stretching). The
(negative) evolution of the 785 cm-1 feature clearly follows that of the characteristic 465 cm-1
DOX feature, saturating at ~ 12 hrs. The feature at 1047 cm-1 continues to evolve, however, as
the metabolism of the nucelolus responds to the drug interactions.
The previous study by Farhane et al.,[39] using multivariate statistical analysis, consisting of
Partial Least Squares Regression (PLSR) and Independent Components Analysis (ICA)
showed a similar chemical binding signature in the nucleoli of the cells after short term DOX

exposure for both A549 and Calu-1 cell lines, related to RNA/DNA interaction, resulting in a
decrease of both bands at 785 cm−1 (DNA backbone O–P–O) and 813 cm−1 (RNA O–P–O
phosphodiester band stretching). The signatures of the nucleolar interactions for both cell lines
are remarkably similar to the profile of the (1047 cm-1) cross section of the asynchronous
component of the two dimensional correlation analysis, further associating it with the signature
of the direct binding of the drug in the cell.
The uptake of DOX in the nucleolus, and the DOX-RNA/DNA intercalation is seen to saturate
after 2-6 hrs.[39] After saturation, for the nucleolar regions, Independent Components Analysis
(ICA) of the later exposure times revealed a notable decrease in cellular features at 728 cm-1
(adenine) 785 cm-1 (cytosine, thymine and DNA backbone O–P–O), 813 cm-1 (RNA O–P–O
stretching), 1095 cm-1 (DNA PO2_ symmetric stretching) and 1376 cm-1 (thymine), consistent
with a decrease in nucleic acid contributions due to the DOX mechanism of action inducing
alteration of nucleolar structure, size, shape and as a consequence cellular apoptosis.[41] These
characteristics are consistent with the features of the (1217 cm-1) cross section of the
asynchronous component of the two dimensional correlation analysis.
Notably, very similar profiles were observed for the case of Raman microspectroscopic
analysis of the nucleolar regions of similarly DOX exposed Calu 1, non-small-cell lung cancer
cells, as shown in Supplemental Figures S1-S2. It is notable, however, that the asynchronous
cross sections of A549 and Calu 1 cells (Figure S2(b)) at 1217 cm-1 are significantly different.
This was also observed in the multivariate analysis of Farhane et al.,[39] and was proposed to
potentially hold the key to the different sensitivities of the two cell lines to the drug, related to
anti-apoptotic and DNA repair mechanisms.[31]

5. Conclusions

As example of a label free analytical technique, Raman microspectroscopy has been
demonstrated to be a viable alternative to expensive and time consuming conventional high
content analysis protocols. Nevertheless, it is important that the information that the spectral
profiling can yield can be effectively and efficiently data mined. This work demonstrates that
two dimensional correlation analysis of Raman microspectroscopic signatures of the
subcellular interactions of drugs in vitro can identify and differentiate the characteristic
signatures of the initial chemical binding of the drug, and the subsequent cellular response, in
a single operation. The use of simulated datasets provides a valuable validation of the
technique, confirming that the true temporal evolutions of the identified characteristic features
are faithfully reproduced. The study further illustrates the potential of Raman
microspectroscopic subcellular analysis for cytological processes, and the similarities of the
initial binding signatures in different cell lines suggest applications for in vitro preclinical
candidate drug screening, which the differences in the response signatures for different cell
lines suggest sensitivities of the technique to cellular resistance pathways and potential
applications in patient screening for Companion Diagnostics strategies.

Supporting Information
Additional supporting information may be found in the online version of this article at the
publisher’s website.
Figure S1: (a) Synchronous contour plot of the two dimensional correlation analysis of
experimental data of Raman microspectroscopic analysis of the nucleoli of Calu 1 cells
exposed to DOX. The 0 hrs non exposed control has been subtracted as a static component.
(b) Asynchronous contour plot of the two dimensional correlation analysis of experimental
data of Raman microspectroscopic analysis of the nucleoli of Calu 1 cells exposed to DOX.
The dashed lines indicates the vertical cross sections at 1047 cm-1 and 1217 cm-1.

Figure S2: (a) Vertical cross section of the asynchronous correlation analysis (Figure S1(b))
at a wavenumber of 1217 cm-1. (b) Vertical cross section of the asynchronous correlation
analysis (Figure S1(b)) at a wavenumber of 1047 cm-1.
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Figure 1: Schematic representation of workflow of (i) cell culture (ii) drug exposure (iii)
cytotoxicity assessment (iv) cell fixation and subcellular Raman microspectroscopic analysis
(v) data preprocessing (v) two dimensional correlation analysis

Figure 2: (a) Average Control spectra of the nucleoli of A549 cells. Also shown are the
simulated spectral signatures of DOX binding (Response 1) and subsequent cellular response
(Response 2). Spectra are normalised to a maximum intensity of 1. Band wavenumbers are: 1.
785 cm-1, 2. 810 cm-1, 3. 1047 cm-1, 4. 1095 cm-1, 5. 1271 cm-1, 6. 1444 cm-1, 7. 1683 cm-1, (b)
Simulated time evolution of the cellular spectral responses to DOX uptake in the A549 cell
nucleolus, (c) Mean Control spectra of A549 nucleolus, and spectra with added simulated
responses, between 700 and 1200 cm-1, after 20 and 72 hrs DOX exposure.
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Figure 3: Synchronous contour plot of two dimensional correlation analysis of A549 nucleolar
spectra with simulated response to DOX exposure over the time period 0-72 hrs, (a) before and
(b) after subtraction of the control (0 hrs) spectrum as static component. Dashed lines in (b)
show the autocorrelation diagonal and the vertical cross section at x= 785 cm-1.
(a)

(b)

Figure 4 (a) Diagonal autocorrelation peaks of two dimensional correlation analysis of A549
nucleolar spectra with simulated response to DOX exposure over the time period 0-72 hrs. (b)
vertical section of synchronous correlation analysis at 785 cm-1, after subtraction of the control
(0hr) spectrum as static component. Band wavenumbers are: 1. 785 cm-1, 2. 810 cm-1, 3. 1047
cm-1, 4. 1095 cm-1, 5. 1271 cm-1, 6. 1444 cm-1, 7. 1683 cm-1
(a)

(b)

Figure 5: (a) Asynchronous contour plot of two dimensional correlation analysis of A549
nucleolar spectra with simulated response to DOX exposure over the time period 0-72 hrs.
Dashed lines show the diagonal and vertical cross sections at x= 785 cm-1 and x=1047 cm-1 (b)
vertical section of asynchronous correlation analysis at 785 cm-1 (solid line) and 1047 cm-1
(dotted line). Band wavenumbers are: 1. 785 cm-1, 2. 810 cm-1, 3. 1047 cm-1, 4. 1095 cm-1, 5.
1271 cm-1, 6. 1444 cm-1, 7. 1683 cm-1
(a)

(b)

Figure 6: Autocorrelation intensity for the features at 785 cm-1 and 1047 cm-1, with (a) an
increasing correlation window 0-T, in intervals of 4 hrs (b) a moving correlation window T =
4hrs. (c) shows the evolution of the spectral features at 785 cm-1 (Response 1) and 1047 cm-1
(Response 2) as identified by the MIDAS 2010, after subtraction of the static component.
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Figure 7: (a) Synchronous contour plot of the two dimensional correlation analysis of
experimental data of Raman microspectroscopic analysis of the nucleoli of A549 cells exposed
to DOX. The 0 hrs non exposed control has been subtracted as a static component. (b)
Asynchronous contour plot of the two dimensional correlation analysis of experimental data of
Raman microspectroscopic analysis of the nucleoli of A549 cells exposed to DOX. The dashed
lines indicate the vertical cross sections at 1047 cm-1 and 1217 cm-1.
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Figure 8: Diagonal autocorrelation of (Figure 7(a)) synchronous correlation analysis of
experimental data of Raman microspectroscopic analysis of the nucleoli of A549 cells exposed
to DOX. The 0 hrs non exposed control has been subtracted as a static component.
Characteristic DOX features are indicated as: 1. 440 cm-1, 2. 465 cm-1, 3. 1200 cm-1, 4. 1300
cm-1, 5. 1445 cm-1, 6. 1570 cm-1.

Figure 9: (a) Vertical cross section of the asynchronous correlation analysis (Figure 7(b)) at a
wavenumber of 1217 cm-1. DOX features are indicated by 1. 440 cm-1, 4. 1220 cm-1. Cellular
response features are indicated by 2. 1047 cm-1, 3. 1200 cm-1, 5. 1300 cm-1, 6. 1440 cm-1 (b)
Vertical cross section of the asynchronous correlation analysis (Figure 7(b)) at a wavenumber
of 1047 cm-1. Features at 1. 785 cm-1, 2. 810 cm-1, 3. 1090 cm-1, 4. ~1640 cm-1 are indicated.
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Figure 10: Temporal evolution of the spectroscopic features of the DOX exposed A549
nucleolus as a function of time. Solid lines are a guide to the eye.

